Rosetta Genomics, Rabin Medical Center deal

Rosetta and not-for-profit Rabin Medical Center partnered to develop a non-invasive microRNA-based assay to diagnose chronic allograft dysfunction in kidney transplant recipients. Rosetta will partial...